Search Within


Applied Filters:
Showing 1-30 of 30 results for "PHR1362" within Papers
Spontaneous bilateral humeral shaft fracture due to severe renal osteodystrophia.
Yalcin Solak et al.
The American journal of the medical sciences, 342(1), 55-55 (2011-05-04)
Potential interaction between sevelamer and fat-soluble vitamins: a hypothesis.
Paweena Susantitaphong et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation, 59(2), 165-167 (2012-01-17)
Tin Wui Wong et al.
Drug development and industrial pharmacy, 38(12), 1417-1427 (2012-02-09)
Alginate-chitosan pellets prepared by extrusion-spheronization technique exhibited fast drug dissolution. This study aimed to design sustained-release alginate pellets through rapid in situ matrix coacervation by chitosan during dissolution. Pellets made of alginate with chitosan and/or calcium acetate were prepared using
Isabelle Zamfirescu et al.
Thyroid : official journal of the American Thyroid Association, 21(5), 483-486 (2011-05-21)
Calcium carbonate is a commonly used dietary supplement and has been shown to interfere with levothyroxine absorption. However, calcium citrate, which is also used for supplementation purposes, has not been studied previously and calcium acetate, which is used to treat
Geoffrey A Block et al.
Journal of the American Society of Nephrology : JASN, 23(8), 1407-1415 (2012-07-24)
Some propose using phosphate binders in the CKD population given the association between higher levels of phosphorus and mortality, but their safety and efficacy in this population are not well understood. Here, we aimed to determine the effects of phosphate
Kohei Hironaka et al.
Biological & pharmaceutical bulletin, 34(6), 894-897 (2011-06-02)
We examined the feasibility of using submicron-sized liposomes (ssLips) for retinal delivery of hydrophilic compounds, which would also have a wide range of applications. To evaluate the uptake into conjunctival cell line and the intraocular behavior of hydrophilic compound-containing ssLips
Genevieve Holzapfel et al.
Biochemistry, 51(31), 6114-6126 (2012-08-01)
Ras GTPase cycles between its active GTP-bound form promoted by GEFs and its inactive GDP-bound form promoted by GAPs to affect the control of various cellular functions. It is becoming increasingly apparent that subtle regulation of the GTP-bound active state
Mahmut Ilker Yilmaz et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation, 59(2), 177-185 (2011-12-06)
Fibroblast growth factor 23 (FGF-23) is a marker of endothelial dysfunction and atherosclerotic complications in patients with chronic kidney disease (CKD). Because previous studies suggested that sevelamer may exert effects on FGF-23 level and endothelial function independently of its phosphate-lowering
Melanie Gorman Ng et al.
The Annals of occupational hygiene, 57(5), 627-639 (2013-01-15)
Although dustiness and viscosity are potential determinants of dermal exposure, their effect on exposure is poorly understood. The goal of this study was to investigate the effect of dustiness and viscosity on dermal exposure by each of three dermal exposure
Adrian Covic et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 28(9), 2383-2392 (2013-06-22)
Different phosphate binders exert differing effects on bone mineral metabolism and levels of regulating hormones. The objective of this post hoc evaluation of the CALcium acetate MAGnesium carbonate (CALMAG) study was to compare the effects of calcium acetate/magnesium carbonate (CaMg)
[Ultrastructural cellular alterations of the natronophilic endoevaporite cyanobacterium Euhalothece natronophila during fossilization].
O I Baulina et al.
Mikrobiologiia, 80(6), 787-795 (2012-03-08)
Sankar D Navaneethan et al.
Clinical nephrology, 82(1), 16-25 (2014-06-03)
Higher serum phosphorus is associated with an increased mortality among those with chronic kidney disease (CKD). We examined the practice patterns of phosphate binder use to lower serum phosphorus levels and their associations with mortality in the non-dialysisdependent CKD population.
Meagan L Harless et al.
Environmental toxicology and chemistry, 30(7), 1637-1641 (2011-04-08)
Widespread and intensive application of road deicers, primarily road salt (NaCl), in North America threatens water quality and the health of freshwater ecosystems. Intensive use of NaCl can be harmful to sensitive members of freshwater ecosystems such as amphibians. Detection
Juan F Navarro-González et al.
Clinical journal of the American Society of Nephrology : CJASN, 6(9), 2272-2279 (2011-07-26)
Hyperphosphatemia and subclinical endotoxemia are important sources of inflammation in HD. Proinflammatory cytokines are strong correlates of soluble CD14 (sCD14) concentrations, an independent predictor of mortality in this population. We evaluated the effects of calcium acetate and sevelamer hydrochloride on
Rodrigo B de Oliveira et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 28(10), 2510-2517 (2013-08-27)
Mineral bone disorder (MBD) is an early complication of chronic kidney disease (CKD), with complex interactions in the bone-kidney-energy axis. These events lead to impaired bone remodelling, which in turn is associated with cardiovascular disease. Recently, we reported on a
Anne-Cécile Boulay et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience, 35(10), 4427-4439 (2015-03-13)
In the normal brain, immune cell trafficking and immune responses are strictly controlled and limited. This unique homeostatic equilibrium, also called brain immune quiescence, is crucial to maintaining proper brain functions and is altered in various pathological processes, from chronic
Tineke M De Schutter et al.
Kidney international, 83(6), 1109-1117 (2013-03-15)
Calcium-based phosphate binders are used to control hyperphosphatemia; however, they promote hypercalcemia and may accelerate aortic calcification. Here we compared the effect of a phosphate binder containing calcium acetate and magnesium carbonate (CaMg) to that of sevelamer carbonate on the
C B Ustundag et al.
The journal of physical chemistry. B, 117(6), 1571-1576 (2012-07-12)
Hydroxyapatite (HA) coatings have been used to improve biological and mechanical fixation of metallic prosthesis. Because of extraordinary features of carbon nanotubes (CNTs), they have a lot of facilities, such as extremely strong nanoreinforcement materials for composites. HA powders were
Sophie A Jamal et al.
Lancet (London, England), 382(9900), 1268-1277 (2013-07-23)
Phosphate binders (calcium-based and calcium-free) are recommended to lower serum phosphate and prevent hyperphosphataemia in patients with chronic kidney disease, but their effects on mortality and cardiovascular outcomes are unknown. We aimed to update our meta-analysis on the effect of
Alastair J Hutchison et al.
Nature reviews. Nephrology, 7(10), 578-589 (2011-09-07)
The ideal serum level of phosphate in patients on dialysis, and the benefits of controlling levels of phosphate in serum remain unclear despite observational studies that associate phosphate levels with mortality. In the absence of robust data from trials, current
Anne M Huml et al.
Renal failure, 34(10), 1258-1263 (2012-09-28)
Because hemodialysis treatment has a limited ability to remove phosphorus, dialysis patients must restrict dietary phosphorus intake and use phosphorus binding medication. Among patients with restricted dietary phosphorus intake (1000 mg/d), phosphorus binders must bind about 250 mg of excess phosphorus per
Phosphate binders in CKD: bad news or good news?
Tilman B Drüeke et al.
Journal of the American Society of Nephrology : JASN, 23(8), 1277-1280 (2012-07-17)
Y K Pan et al.
Colloids and surfaces. B, Biointerfaces, 109, 1-9 (2013-04-23)
Calcium phosphate (CaP) coatings were prepared on Mg-Zn-Zr magnesium alloy by micro-arc oxidation (MAO) in electrolyte containing calcium acetate monohydrate (CH3COO)2Ca·H2O) and different phosphates (i.e. disodium hydrogen phosphate dodecahydrate (Na2HPO4·12H2O), sodium phosphate (Na3PO4·H2O) and sodium hexametaphosphate((NaPO3)6)). Scanning electron microscope (SEM)
Lukas Witt et al.
Analytical chemistry, 86(13), 6439-6446 (2014-05-28)
Glycosaminoglycans (GAGs) are a class of heterogeneous, often highly sulfated glycans that form linear chains consisting of up to 100 monosaccharide building blocks and more. GAGs are ubiquitous constituents of connective tissue, cartilage, and the extracellular matrix, where they have
Daniel T Grima et al.
Current medical research and opinion, 29(2), 109-115 (2012-12-12)
The avoidance of hospitalizations and the maintenance of in-center dialysis sessions in patients receiving dialysis for end-stage renal disease (ESRD) have obvious benefits to patients, dialysis providers and payers. Benefits include better continuity of care, better patient outcomes, improved quality
Calcium acetate, an effective phosphorus binder in patients with renal failure
Mai LM, et al.
Kidney International, 36(4), 690-695 (1989)
Chronic kidney disease: calcium-based versus non-calcium-based phosphate binders: effect on mortality in patients with CKD.
Susan J Allison
Nature reviews. Nephrology, 9(9), 491-491 (2013-08-07)
Leonardo V Riella et al.
American journal of kidney diseases : the official journal of the National Kidney Foundation, 57(4), 641-645 (2011-02-22)
Hypophosphatemia is a common complication after kidney transplant, affecting >90% of patients. However, no specific recommendations for phosphate repletion exist for transplant recipients. We report a case of a 70-year-old highly sensitized woman with end-stage renal disease caused by diabetic
Theresa Geis et al.
Experimental cell research, 331(1), 46-57 (2014-12-10)
Hypoxia promotes progression of hepatocellular carcinoma (HCC), not only affecting tumor cell proliferation and invasion, but also angiogenesis and thus, increasing the risk of metastasis. Hypoxia inducible factors (HIF)-1α and -2α cause adaptation of tumors to hypoxia, still with uncertainties
Chronic kidney disease: Phosphate binder therapy--cracks in the tower of strength?
Pieter Evenepoel et al.
Nature reviews. Nephrology, 8(11), 615-616 (2012-10-10)
Page 1 of 1